<DOC>
	<DOCNO>NCT02377700</DOCNO>
	<brief_summary>Xeltis develop biodegradable patch prosthesis , Vascular Patch Model COR-VP-001 , use vascular patch augment pulmonary trunk pulmonary artery . The prosthesis immediately mechanically functional , physiochemical characteristic enable cell infiltration tissue formation . The Xeltis Vascular Graft Model COR-VP-001 specifically design improve surgical outcome reduce synthetic material relate complication improve hemodynamic characteristic .</brief_summary>
	<brief_title>Safety Performance Vascular Patch Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis</brief_title>
	<detailed_description>Xeltis develop medical device treat pediatric cardiovascular patient require RVOT reconstruction . Xeltis ' mission offer 'Solutions Lifetime ' cardiovascular patient . Xeltis develop unique technology base novel biodegradable bio-materials allow regrowth natural heart valve blood vessel patient ' body cell . The principle Xeltis ' COR technology ( COR stand Cardiovascular Organ Regeneration ) implant biodegradable prosthesis blood vessel shape like part replace . The prosthesis immediately mechanically functional , physiochemical characteristic enable cell infiltration tissue formation . Tissue regenerate functional time polymer biodegrade .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>1 . Patient require bidirectional cavapulmonary anastomosis 2 . Male Female 3 . Age : 2 month 16 year 1 . Main Exclusion Criteria Arrhythmias determine ECG and/or investigator 's discretion 2 . Other clinically significant malformation 3 . Coagulation disorder define INR outside normal value , PTT &gt; ULN Fibrinogen &lt; LLN and/or investigator 's discretion 4 . HIVinfection 5 . Syphilis ( Treponema pallidum ) 6 . HepatitisB and/or C virus infection 7 . Unwillingness Parental/legal guardian give consent 8 . Treatment investigational product 9 . Known suspected noncompliance , drug alcohol abuse parents/legal guardian 10 . Inability parents/legal guardian follow procedure study , e.g . due language problem 11 . Participation patient another study within 30 day precede present study 12 . Previous enrolment patient current study 13 . Enrolment investigator 's family member , employee dependent person</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>